Skip to content

Ambu AuraGain vs LMA Supreme in Laparoscopic Surgery

Comparison of the Ambu AuraGain vs. LMA Supreme in Paralysed Patients Undergoing Gynecologic Laparoscopic Surgery in the Trendelemburg Position

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02511652
Enrollment
60
Registered
2015-07-30
Start date
2015-06-30
Completion date
2015-12-31
Last updated
2016-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management, Laparoscopy, Supraglottic Airway Devices

Brief summary

The aim of the study is to compare the performance of two supraglottic airway devices (SGA), the new Ambu AuraGain and the LMA Supreme, in sixty female patients undergoing gynaecologic laparoscopy in the trendelemburg position. Primary outcome is the airway seal pressure. Secondary outcomes are ease of insertion, quality of ventilation, endoscopic view of the glottis, gastric tube passage and complications.

Detailed description

The patients are randomly assigned to 2 groups: * Group 1: Ambu AuraGain. * Group 2: LMA Supreme, Teleflex Procedure: The investigation protocol contains the following sections: 1. Induction of anaesthesia. Intravenous infusion of remifentanil and propofol targeting the effect site (2-4 ng/ml and 4-6 µg/ml respectively). No muscle relaxant will be used for insertion of the SGA. Rocuronium 0.2 mg/Kg will be administered before initiation of pneumoperitoneum. 2. Insertion of the SGAs. The size of the SGA device used is based on the manufacturers' recommendations. All devices are deflated a lubricated prior to use. Once inserted, the cuff is be inflated with a manometer up to 60 cm H20 Position of the device is adjusted if needed. Data recorded: size of SGA, time an number of attempts. 3. Fibreoptic evaluation of the SGAs anatomical position: complete view of the vocal cords (I), epiglottis visible inside, but not causing obstruction (II), epiglottis visible and obstructing the glottic inlet (III), or glottic structures not identified (IV). 4. Functionality of the gastric drainage channel of the SGAs: passage of a 16 G size tube. 5. Measurement of airway seal pressure (oropharyngeal leak pressure (OLP): at baseline, and at 15, 30 and 60 minutes. The maximum pressure allowed is 40 cm H2O. 6. Ventilatory mechanics and parameters are measured at baseline, and at 15, 30 and 60 minutes. Perioperative complications: Hiccup, gastric distension, regurgitation / Aspiration, airway obstruction, laryngospasm, dental, mucosal or tongue injury, hypoxia (SpO2 \< 92%) 7. Removal of the SGAs: Presence of blood - 3 level grading (+/++/+++) Postoperative complications: sore throat, hoarseness, dysphonia, dysphagia, dysphagia: 3-point scale

Interventions

DEVICEAmbu AuraGain evaluation

Evaluation of clinical performance in terms of Insertion, ventilation, position and complications

DEVICELMA Supreme evaluation

Evaluation of clinical performance in terms of Insertion, ventilation, position and complications

PROCEDURELaparoscopic surgery

Gynecologic laparoscopic surgery in the trendelemburg position

Sponsors

Ambu A/S
CollaboratorINDUSTRY
Hospital Clinic of Barcelona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients evaluated as eligible for a SGA * ASA I-III * Without criteria for difficult airway * Body Mass Index ≤ 35 kg/m2 * The patient has signed the Informed Consent * The patient understands his or hers rights and consequences related to this investigation

Exclusion criteria

* Planned operation time \> 2 hours * High risk of regurgitation * Respiratory tract pathology * Preoperative sore throat * Patients with a known or predicted difficult airway * Patients diagnosed with dementia or any mental handicaps * Patient who has a guardian.

Design outcomes

Primary

MeasureTime frameDescription
Airway seal pressureAt 15 minutesMaximum airway pressure that the device can achieve without oropharyngeal leak of gas.

Secondary

MeasureTime frameDescription
Change in Quality of ventilationAt baseline and at 15, 30 and 60 minutesnumber of manoeuvres/corrections required
Ease of insertion of the deviceBaselineTime needed to insert the device
Endoscopic view of glottic structuresAt 15 minutesAssessment of alignment with the glottic inlet as: complete view of the vocal cords (I), epiglottis visible inside, but not causing any obstruction (II), epiglottis visible and causing obstruction (III) or glottis not identified (IV)
Gastric tube insertionAt 5 minutesEase of passage of a gastric tube as: easy, difficult or impossible
Incidence of perioperative complications2 hoursnumber of patients with adverse events: Airway obstruction, desaturation, Aspiration, oropharyngeal trauma, sore throat

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026